How One of the First Cases of CRE “Nightmare Bacteria” on the West Coast was Identified

By the bioMérieux Connection Editors The incidence of Carbapenem-Resistant Enterobacteriaceae (CRE) infection in U.S. hospitals has been growing steadily for the last decade. This spread is due to the acquisition of the carbapenemase genes since the first carbapenemase producer was identified in 1993, according to the Centers of Disease Control and Prevention (CDC). Since then, …